6/18/24 16:05 | 6/14/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Martin Samuel Bates | NJ | O | SVP,CFO | M.d | 205 | 10.16 | 0 | 20 | 254 | 28 | D | | | | | | | | | | | | | | |
6/18/24 16:05 | 6/14/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Martin Samuel Bates | NJ | O | SVP,CFO | S.d | -608 | 35.42 | 0 | -17 | -38 | 28 | D | | | | | | | | | | | | | | |
6/3/24 16:05 | 5/30/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Martin Samuel Bates | NJ | O | SVP,CFO | M.d | 260 | 10.38 | 0 | 25 | 999% | 25 | D | | | | | | | | | | | | | | |
6/3/24 16:05 | 5/30/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Martin Samuel Bates | NJ | O | SVP,CFO | S.d | -1,192 | 34.05 | 0 | -35 | -58 | 25 | D | | | | | | | | | | | | | | |
1/4/24 16:05 | 1/2/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Martin Samuel Bates | NJ | O | SVP,CFO | M.d | 30 | 2.78 | 0 | 11 | 44 | 35 | D | | | | | | | | | | | | | | |
8/15/22 16:16 | 8/11/22 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Martin Samuel Bates | NJ | O | SVP,CFO | M.dm | 95 | 4.75 | 0 | 20 | 457 | 24 | D | | | | | | | | | | | | | | |
8/15/22 16:16 | 8/11/22 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Martin Samuel Bates | NJ | O | SVP,CFO | S.dm | -730 | 36.52 | 0 | -20 | -45 | 24 | D | | | | | | | | | | | | | | |